Loading clinical trials...
Loading clinical trials...
Investigation of the potential prognostic role of non-invasive myocardial work in patients receiving veno-arterial extracorporeal membrane oxygenation therapy.
The study aims to examine the prognostic role of non-invasive myocardial work in veno-arterial extracorporeal membrane oxygenation therapy patients. Subjects with cardiogenic shock regardless of etiology will be enrolled 48-72 hours after the initiation of mechanical circulatory support. It is hypothesized that non-invasive myocardial work may be an independent prognosticator of the outcome.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
No
Semmelweis University Heart and Vascular Center
Budapest, BP, Hungary
Start Date
June 1, 2024
Primary Completion Date
June 1, 2025
Completion Date
December 1, 2025
Last Updated
April 18, 2024
100
ESTIMATED participants
Lead Sponsor
Semmelweis University Heart and Vascular Center
Collaborators
NCT01524276
NCT06154044
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07136532